CN108186671A - For eliminating the hypertonic salt solution and application method of various skin infection diseases - Google Patents
For eliminating the hypertonic salt solution and application method of various skin infection diseases Download PDFInfo
- Publication number
- CN108186671A CN108186671A CN201810022159.1A CN201810022159A CN108186671A CN 108186671 A CN108186671 A CN 108186671A CN 201810022159 A CN201810022159 A CN 201810022159A CN 108186671 A CN108186671 A CN 108186671A
- Authority
- CN
- China
- Prior art keywords
- salt solution
- skin
- hypertonic salt
- skin infection
- hypertonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention is suitable for skin infection disease treatment field, provides a kind of hypertonic salt solution and application method for being used to eliminate various skin infection diseases, and component contained by the hypertonic salt solution is as follows：Sodium chloride (NaCl) 0.91% 35%, hexamethylene (PHMB) 0.0001% 1%, chlorohexidene (Chlorhexidine) 0.001% 3%, Bole Sha Mu (Synperonic pe (R)/F86) 0.1% 10% and water, the hypertonic salt solution is in the use of 20 to 45 degrees Celsius of environment, invade bubble or soak damaged skin, daily one to secondary, each usage time 20 40 minutes, continuously or discontinuously using 7 to 15 times.Using after this hypertonic salt solution, since human skin cell's film main component is protein, salt can be resisted, cell is not damaged, and volume is reduced in only meeting dehydration, so as to concede drug channel, drug is enable to reach skin deep part and hair follicle root, and the cell membrane main component of microorganism is phosphatide, easily breaks ring by hypertonic salt solution and chemical agent, the microorganisms such as bacterium, fungi, protozoon are killed, skin is made to get well.
Description
Technical field
The invention belongs to dept. of dermatology field more particularly to a kind of hypertonic salt for being used to eliminate various skin infection diseases are molten
Liquid and application method.
Background technology
Skin is the organ of human body maximum, and skin infection disease is a major class in skin disease, is by pathogen
Disease caused by invading skin.Under normal conditions, due to the change of living condition, hygienic conditions etc., it is easy to various senses occur
Metachromia skin disease.The pathogen of skin infection disease is largely invaded by skin, such as various wart classes caused by virus, fungi
Caused dermatophytosis, leprosy, tuberculosis caused by coccigenic suppurative dermatosis, bacillus, animal schistosomes cercaria are drawn
The schistosome cercarial dermatitis risen, scabies etc. caused by itch mite.The method of existing treatment skin infection disease, is mostly outer painting needle
To pathogen medication, the infection of skin surface can only be treated, it is impossible to go deep into skin corium and kill pathogenic microorganism, so it is difficult to effecting a radical cure
Deep skin infection (deep skin as erysipelas involves the infection of lymphatic vessel net and the epifolliculitis of facial recurrent exerbation),
Achieve the purpose that effect a permanent cure.
Invention content
In view of the above problems, the purpose of the present invention is to provide a kind of for eliminating the hypertonic of various skin infection diseases
Salting liquid and application method, it is intended to which the skin corium kill micro- life of cause of disease cannot be goed deep by solving existing skin infection disease therapeuticing medicine
The technical issues of object.
The present invention adopts the following technical scheme that：
It is described for eliminating the hypertonic salt solutions of various skin infection diseases, it includes component and each component quality
Per distribution ratio is as follows：
It is described as follows for the application method of hypertonic salt solution of eliminating various skin infection diseases：
Under 20 to 40 degrees celsius, bubble or soak damaged skin are invaded, daily one to secondary, continuously or discontinuously uses
7 to 15 times.
Further, each duration 20-40 minutes.
The beneficial effects of the invention are as follows：Using after this hypertonic salt solution, since human skin cell's film main component is egg
White matter can resist salt, and cell is not damaged, and volume is reduced in only meeting part dehydration, so as to concede iuntercellular drug channel, makes medicine
Object can reach skin deep part and hair follicle root, and the cell membrane main component of microorganism is phosphatide, easily by hypertonic salt solution and
Chemical agent breaks ring, kills the microorganisms such as bacterium, fungi, protozoon, skin is made to get well, realization radical cure deep skin infection,
Achieve the purpose that effect a permanent cure.
Specific embodiment
In order to make the purpose , technical scheme and advantage of the present invention be clearer, with reference to embodiments, to the present invention
It is further elaborated.It should be appreciated that the specific embodiments described herein are merely illustrative of the present invention, it is not used to
Limit the present invention.
In order to illustrate technical solutions according to the invention, illustrated below by specific embodiment.
It is of the present invention for eliminating the hypertonic salt solutions of various skin infection diseases, it includes component and each group
Divide percent mass proportioning as follows：
Sodium chloride content determines the concentration of hypertonic salt solution in above-mentioned each component, and the content of sodium chloride is no more than 35%
Preferably.In addition the hexamethylene is a kind of high-efficient antibacterial agent, and main pharmacological is the destruction of specificity
The microbial cell film being made of phosphatide, and human cell's film as main component does not damage to protein.Colorless and odorless, suppression
Bacteria concentration is low, and wide spectrum low toxicity, work fast, foam volume is low, and can form one layer of cation in article surface and persistently grow
Time it is antibacterial, and will not cause generation antibacterial bacteria characteristic.In this formula synergistic effect is generated with hypertonic salt.Chlorohexidene
It is a kind of wide-spectrum bactericide, also has special efficacy to microorganisms such as fungi and protozoons, more wide spectrum is played in this formula and fights micro- life
The effectiveness of object.Stabilizations of the Bole Sha Mu as hypertonic salt solution, plays a role to the stability of entire solution.
By the content range for rationally setting each component so that the hypertonic salt solution finally obtained has good skin sense
Infectious diseases therapeutic effect.When specifically used, under 20 to 40 degrees celsius, immersion or soak damaged skin are held every time
Continuous time 20-40 minute.Daily one to secondary, continuously or discontinuously using 7 to 15 times.The hypertonic salt solution can be used directly
On the skin, it can also be used, for example as facial mask replenishers, hypertonic salt solution is sprayed on facial mask, so with soak mode
User uses afterwards, can realize user's face skin infection disease treatment.The deep skin as erysipelas involves lymph
The treatment of the epifolliculitis (being also the skin diseases such as acne) of the infection of pipe network and facial recurrent exerbation.
The foregoing is merely illustrative of the preferred embodiments of the present invention, is not intended to limit the invention, all essences in the present invention
All any modification, equivalent and improvement made within refreshing and principle etc., should all be included in the protection scope of the present invention.
Claims (3)
- A kind of 1. hypertonic salt solution for being used to eliminate various skin infection diseases, which is characterized in that the hypertonic salt solution packet The component and each component percent mass proportioning contained is as follows：
- 2. a kind of application method for the hypertonic salt solution for being used to eliminate various skin infection diseases, which is characterized in that process is such as Under：Under 20 to 40 degrees celsius, bubble or soak damaged skin are invaded, daily one to secondary, is continuously or discontinuously arrived using 7 15 times.
- 3. it is used to eliminate the application method of the hypertonic salt solution of various skin infection diseases, feature as claimed in claim 2 It is, each duration 20-40 minutes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810022159.1A CN108186671A (en) | 2018-01-10 | 2018-01-10 | For eliminating the hypertonic salt solution and application method of various skin infection diseases |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810022159.1A CN108186671A (en) | 2018-01-10 | 2018-01-10 | For eliminating the hypertonic salt solution and application method of various skin infection diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108186671A true CN108186671A (en) | 2018-06-22 |
Family
ID=62588554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810022159.1A Pending CN108186671A (en) | 2018-01-10 | 2018-01-10 | For eliminating the hypertonic salt solution and application method of various skin infection diseases |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108186671A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101579307A (en) * | 2008-05-14 | 2009-11-18 | 北京申科联华科技有限公司 | Application of hypertonic injection to preparation of medicament accelerating wound healing |
| CN101909653A (en) * | 2007-12-27 | 2010-12-08 | K·M·阿韦林 | Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| CN102335452A (en) * | 2011-09-22 | 2012-02-01 | 边俊杰 | Formula of functional dressing and preparation method thereof |
-
2018
- 2018-01-10 CN CN201810022159.1A patent/CN108186671A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101909653A (en) * | 2007-12-27 | 2010-12-08 | K·M·阿韦林 | Composition exhibiting high osmotic antimicrobial, anti-inflammatory and regeneration activity |
| CN101579307A (en) * | 2008-05-14 | 2009-11-18 | 北京申科联华科技有限公司 | Application of hypertonic injection to preparation of medicament accelerating wound healing |
| CN102335452A (en) * | 2011-09-22 | 2012-02-01 | 边俊杰 | Formula of functional dressing and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 孙艳茹，律秀珍: "大盐水溶液治疗褥疮的护理体会", 《实用护理杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6426066B1 (en) | Use of physiologically balanced, ionized, acidic solution in wound healing | |
| ES2565991T3 (en) | Therapeutic composition and use | |
| GB2355190A (en) | Super-oxidised water based on hypochlorous acid in medical treatment | |
| US5855922A (en) | Antiseptic composition and process for prophylaxis and therapeutic treatment of dermal disorders | |
| BRPI0609429A2 (en) | USE OF A WATER SOLUTION WITH OXIDATIVE REDUCING POTENTIAL (ORP) | |
| WO2004012748A1 (en) | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing | |
| CN104490630A (en) | No-washing foam hand disinfection solution and preparation method thereof | |
| CN110151586A (en) | A kind of net acne DEAGE CRD TONER of chamomile and preparation method thereof | |
| CN108135166A (en) | Prevent the method for the tissue field planting and the biomembrane in processing animal tissue of pathogen | |
| JP2012509870A (en) | Perfluorocarbon gel formulation | |
| TW201216859A (en) | Disinfectant and antiseptic formulation having reduced iodine content | |
| US8557265B2 (en) | Use of a synergistic composition as a therapeutic agent of disinfectant | |
| CN102614113A (en) | Compound washing-free disinfection gel | |
| US20050142215A1 (en) | Antimicrobial compositions and methods of use | |
| RU2480239C2 (en) | Antibacterial agent | |
| CN108186671A (en) | For eliminating the hypertonic salt solution and application method of various skin infection diseases | |
| CN108926577A (en) | A kind of method that electric potential water is used for Wound antibiotic healing cleaning-nursing | |
| EP2068892A1 (en) | Wound healing compositions | |
| WO2007143586A2 (en) | Composition for wound care and method of using same | |
| JP2005104950A (en) | Electrolyzed reductive water for treating athlete's foot | |
| US20200346957A1 (en) | Biofilm disruption leading to microbial destruction | |
| RU2427379C1 (en) | Diabetic foot prevention and care composition | |
| Sandström | The antibacterial effect of silver with different release kinetics | |
| US20230017920A1 (en) | Shelf-stable hypochlorous acid | |
| CN109846847A (en) | A kind of effervescent tablet and preparation method thereof for treating animal dermatosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180622 |
|
| RJ01 | Rejection of invention patent application after publication |